pillbase.ru

Praluent

Active substance: alirocumab

alirocumab

Centralised EU authorisationActive

Marketing holder: Sanofi Winthrop Industrie

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Пралуэнт
    раствор для подкожного введения, 150 мг, 1 мл (original in Russian, GRLS)
    ЛП-№(000321)-(РГ-RU)
    Санофи Винтроп Индустрия
  • Пралуэнт
    раствор для подкожного введения, 150 мг/мл, 1 мл (original in Russian, GRLS)
    ЛП-004078
    АО "Санофи-авентис груп"
US 4
  • Praluent
    INJECTION, SOLUTION · ALIROCUMAB 150 mg/mL
    0024-5902
    Sanofi-Aventis U.S. LLC
  • Praluent
    INJECTION, SOLUTION · ALIROCUMAB 75 mg/mL
    0024-5901
    Sanofi-Aventis U.S. LLC
  • Praluent
    INJECTION, SOLUTION · ALIROCUMAB 150 mg/mL
    61755-021
    Regeneron Pharmaceuticals, Inc.
  • Praluent
    INJECTION, SOLUTION · ALIROCUMAB 75 mg/mL
    61755-020
    Regeneron Pharmaceuticals, Inc.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-357c-774d-87a5-cff914d8cf28,01a120c5-1ce6-701d-a310-7b23bd62e7b6;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-4c70-753b-a902-17800c28751d,01a12091-f06d-78b7-9d28-8544f4674b87,01a12098-ed2d-7774-9b81-ba22e4f20420,01a1209d-b172-78e4-917e-82f4e0722aa6;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003882
Registration status
Active
ATC code
C10AX14
Sources
  • product · EMA · EMEA/H/C/003882 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003882 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003882 · Verified 2026-10-09